Raphi Shpitalnik
Junior Member of Macroaxis Editorial Board
Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
Company Analysis | |
raphi@macroaxis.com | |
Raphi Shpitalnik Latest Stories - Published
Monopar Therapeutics (MNPR) is currently navigating a volatile phase, with a high coefficient of variation at 799.27, indicating significant price fluctuations. The stock's 200-day moving average stands at 3.70, suggesting that it has been trading below this level, which could signal a potential rebound if it manages to break above this resistance. However, investors should be cautious, as the biotechnology sector's inherent volatility, reflected in MNPR's beta of 1.261, could lead to further price swings.
Key Takeaways
Monopar Therapeutics has received a "Strong Buy" rating from three analysts.over two weeks ago at Macroaxis By Raphi Shpitalnik |
Not all that glitters is gold, especially when it comes to evaluating stocks like IMAC Holdings. Trading under the ticker BACK on NASDAQ, this company operates in the healthcare sector, specifically within medical care facilities. Despite its promising industry, IMAC Holdings faces significant financial challenges.
over two weeks ago at Macroaxis By Raphi Shpitalnik |
Fortune favors the bold, and Phunware's recent stock performance is a testament to that adage. As the broader market experiences a dip, Phunware has surged, catching the eye of investors looking for promising opportunities. Despite its volatile nature, with a price action indicator of 1.77 and a rate of daily change at 1.21, the stock's potential upside price of 23.51 suggests significant room for growth.
over two weeks ago at Macroaxis By Raphi Shpitalnik |
Comerica (NYSE: CMA) is catching the eye of investors who are increasingly optimistic about its potential. With a Sortino Ratio of 0.0377, the stock is showing a promising risk-adjusted return, which suggests that it could be a smart play for those looking to balance risk and reward. As the stock opened at 62.32 and reached a high of 63.27, there's a palpable sense of momentum that could translate into tangible gains for those willing to ride the wave.
Primary Takeaways
Macroaxis offers an impartial investment recommendation for Comerica, designed to complement existing analyst and expert opinions.over three weeks ago at Macroaxis By Raphi Shpitalnik |
As we look ahead to November 2024, KeyCorp (NYSE: KEY) presents an intriguing opportunity for investors considering its current market dynamics. With an EPS estimate for next year at 1.51, the company shows potential for earnings growth, which could attract more investor interest. Additionally, the stock's PEG ratio of 0.72 suggests that it might be undervalued relative to its growth prospects, making it a potentially attractive buy for those looking to capitalize on regional bank stocks.
over three weeks ago at Macroaxis By Raphi Shpitalnik |
Citizens Financial Group, trading under the ticker NYSE: CFG, stands as a prominent player in the financial services sector, particularly within the banking category. With a current valuation of $23.44 billion, the company offers a robust platform for potential investors to consider. Despite a modest operating margin of 0.27%, Citizens Financial has managed to maintain a steady presence in the market.
over three weeks ago at Macroaxis By Raphi Shpitalnik |
When it comes to choosing between PNC Financial Services and Truist Financial Corp, the devil is in the details. PNC Financial Services, with a market capitalization of $74.9 billion, stands as a formidable player in the regional banking sector. Despite its challenges, including a slight operating margin of 0.35%, PNC's robust net interest income of $14.2 billion showcases its ability to generate revenue from its core banking operations.
over three weeks ago at Macroaxis By Raphi Shpitalnik |
VOXX International, a player in the consumer electronics sector, is catching the eye of investors as a potential strategic buy, especially as the market experiences an upswing. Despite facing challenges, such as a loss in operating income of 27.5 million, the company's stock is trading at a compelling price-to-book ratio of just 0.49X. This suggests that the market may be undervaluing its assets, presenting a unique opportunity for investors willing to look beyond the current financial hurdles.
over a month ago at Macroaxis By Raphi Shpitalnik |
In the world of investing, timing can be everything. As Alpine 4 Holdings (NASDAQ: ALPP) navigates the current market rally, it presents a compelling opportunity for investors looking to capitalize on its potential. Despite recent losses, the stock's valuation real value stands at $1.51, suggesting room for growth compared to its current market value of $0.36.
over a month ago at Macroaxis By Raphi Shpitalnik |
All that glitters is not gold, and Nike (NKE) shareholders may need to take a closer look at their portfolios. Despite a 52-week high of $121.92, recent market dynamics have seen the stock hover around a typical price of $88.63. Analysts are optimistic with 16 strong buy recommendations, yet the stock's price action indicator at -0.86 and a daily balance of power at -0.51 suggest underlying weakness.
over a month ago at Macroaxis By Raphi Shpitalnik |
Latest Stories
Recently Published Macroaxis Headlines